EMKinetics raises $500K for incontinence treatment
EMKinetics, a Santa Cruz, Calif. company that uses electric pulses as a therapy to prevent urinary incontinence, has raised a $500,000 first round of funding, according to VentureWire.
The company is using technology that it licensed from TheraNova. The electric pulses, variously called neuromodulation or neurostimulation, are also used by other companies for pain relief, hypertension and other treatments.
WS Investment, TheraNova and angel investors provided the round. EMKinetics is looking for $5-10 million in a next round.
Next Story: BitGravity scores a big partnership and funding, calling an end to era of small independent CDNs
Previous Story: DEMOfall 08: ffwd goes live with its video programming for the Internet
About the Author, Chris Morrison
Chris Morrison writes about cleantech and environmental issues for VentureBeat, with occasional forays into gaming and semantic technology. He got his start writing about tech for Business 2.0 magazine, but quickly realized new media was the ticket when that institution closed its doors in 2007. Chris has also covered public equities and regulatory issues. He originally hails from southern Virginia, graduated from Evergreen State College in Washington, and now lives in San Francisco.